Leading UK healthcare SaaS business acquired by Canada’s premier wellness platform
TicTrac Ltd has been sold to Dialogue Health Technologies.
TicTrac is a UK-based SaaS provider of a global health and wellness platform. The company supports employers and insurance partners, engaging their employees and customers to improve overall wellness, and driving positive outcomes through meaningful insights. Its go-to-market strategy includes both a business-to-business (B2B) approach, as well as a business-to-insurance (B2I) approach, working with four of the largest global insurance companies.
Dialogue Health Technologies is Canada’s premier virtual healthcare and wellness platform. Its integrated platform improves the health and wellness of organizations by providing access to the most impactful programs in the industry, all in one place.
According to Dialogue, the acquisition of TicTrac represents a unique opportunity to accelerate the development of Dialogue’s Integrated Health PlatformTM (“IHP”) through the addition of a high margin, SaaS-based digital health and wellness offering. The two companies share similar operating cultures of challenging the status quo and are strategically aligned in their respective missions to improve health and well-being. Martin Blinder, co-founder and CEO of TicTrac, will continue to lead the TicTrac team, reporting to Cherif Habib, CEO of Dialogue.
Oaklins Cavendish, based in the UK, acted as sell-side advisor in this transaction.
Talk to the deal team
Ricotto has been acquired by Sitra Group
Ricotto S.r.l. has joint Sitra Group, a Belgium-based and PE-backed international logistic and transportation group.Learn more
M80 Partners has acquired Luminis
Belgian private equity fund M80 has acquired a majority stake in Luminis. M80 offers to software and technology company Luminis the opportunity to further expand its strategy and market position internationally. Luminis becomes part of a platform that also includes XPLUS, a Belgian expert in enterprise IT architecture. M80 plans to make further selective acquisitions in Europe in the coming months with the aim of bringing together a portfolio of best-in-class digital transformation specialists.Learn more
Spice Private Equity Ltd. has had a fairness opinion conducted on a public tender offer by GP Investments
On 14 July 2022, GP Swiss Ltd., a subsidiary of GP Investments, published a public tender offer for all publicly held registered shares of Spice Private Equity Ltd. (Spice). The independent members of the Board of Directors of Spice have had a fairness opinion conducted on the financial adequacy of this public tender offer. The offer price for each Spice share was US$16.25 net in cash. Following a successful offer, GP Investment intends to delist the stock from the SIX Swiss Stock Exchange.Learn more